Achilles Therapeutics

PITCH

Achilles Therapeutics is a biopharmaceutical company developing personalised T cell therapies targeting neoantigens: protein markers unique to each individual that are present on the surface of a cancer cell and can be detected by the immune system.

Based in

Stevenage

Created in

> Website

LATEST INVESTMENT

#BioPharma 11.2020

Achilles Therapeutics

£52.7M

OrbiMed, Boxer Capital, RA Capital, Syncona, Forbion, Invus, Perceptive Advisors & Redmile Group